Development
DexCom, Inc.
DXCM
$82.26
$1.642.03%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 58.70% | 54.44% | 55.30% | 13.50% | 57.31% |
| Total Depreciation and Amortization | 17.53% | 22.74% | 28.41% | 50.21% | 68.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.99% | -105.35% | -72.10% | -56.94% | -49.41% |
| Change in Net Operating Assets | -88.01% | 391.94% | 2,260.76% | 223.65% | 120.23% |
| Cash from Operations | 11.80% | 16.27% | 29.23% | 55.22% | 51.30% |
| Capital Expenditure | 35.14% | 35.10% | 19.93% | 13.60% | 6.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 97.90% | 97.90% | 87.09% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -77.09% | -97.63% | 34.11% | 146.27% | -175.16% |
| Cash from Investing | 2.74% | -35.54% | 30.90% | 42.52% | -141.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.22% | 18.22% | 13.82% | 13.82% | 10.84% |
| Repurchase of Common Stock | -23.49% | 66.16% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -476.88% | -518.13% | -943.93% | -100.00% | -74.75% |
| Cash from Financing | 42.33% | 156.55% | 3,510.91% | -3,768.46% | -5,412.50% |
| Foreign Exchange rate Adjustments | 125.86% | 116.79% | 76.47% | -85.00% | -314.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.53% | 92.72% | 208.73% | -442.69% | -274.30% |